Molnupiravir authorisation comes with a condition – further trials in the next three months, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

According to one of the conditions, as post marketing surveillance the companies will have to submit periodic safety update reports to the drug regulator., According to one of the conditions, as post marketing surveillance the companies will have to submit periodic safety update reports to the drug regulator., , Read More